White House News Manufacturers Of 10 Drugs Chosen For Medicare Price Negotiations Healio

Trump administration unveils Medicare negotiated price cuts for 15 drugs, including Ozempic

The Trump administration late Tuesday announced new lower Medicare prices for 15 drugs that were part of the latest round of the program’s price negotiations, touting a total of $12 billion saved ... Read More

Second Round of Medicare-Negotiated Price Cuts Expected to Save Billions in Drug Costs in 2027

The federal government’s newly announced savings on 15 expensive prescriptions include the popular Ozempic family of weight-loss drugs as well as cancer, COPD and IBS meds. Read More

Trump administration quietly unveils new round of Medicare-negotiated drug prices

WASHINGTON — The Trump administration on Tuesday evening unveiled the prices for 15 drugs that were the subject of Medicare negotiations for the second year, saying it saved $8.5 billion, or 36%, ... Read More

Medicare negotiates price drop for 15 drugs, including Ozempic

The Centers for Medicare & Medicaid Services (CMS) said newly negotiated lower prices for 15 drugs will save 44%, or $12 billion, from last year’s negotiated Medicare spending. The drugs, widely used ... Read More

Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications

Topping the list are Novo Nordisk's blockbuster diabetes injection Ozempic, weight loss shot Wegovy and diabetes pill Rybelsus, which are considered one product in the talks since they all share the ... Read More

Lilly, Novo near White House deals to cut obesity drug prices, gain Medicare access, media reports

(Reuters) -Eli Lilly and Novo Nordisk are expected to announce deals with the White House to offer the lowest dose of their weight-loss drugs at $149 per month, in exchange for Medicare coverage, ... Read More

White House nears deal to lower obesity drug prices for Medicare coverage

The White House is expected to announce a deal this week with Eli Lilly and Novo Nordisk that would lower the price of their popular obesity drugs to $149 per month in some cases, according to four ... Read More

Obesity drugs may be sold at just $149 a month, get covered under Medicare under a reported White House deal in the works

The White House is close to announcing a deal with drugmakers Eli Lilly and Novo Nordisk that would cut the price of obesity drugs to $149 per month in some cases and extend coverage to certain ... Read More